SPDR S&P Pharmaceuticals ETF
XPH
XPH
77 hedge funds and large institutions have $261M invested in SPDR S&P Pharmaceuticals ETF in 2015 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 29 increasing their positions, 29 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
30.04% less ownership
Funds ownership: 61.65% → 31.61% (-30%)
41% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 17
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
Holders
77
Holding in Top 10
–
Calls
$924K
Puts
$788K
Top Buyers
| 1 | +$15.9M | |
| 2 | +$12.5M | |
| 3 | +$10.1M | |
| 4 |
Citigroup
New York
|
+$7.13M |
| 5 |
Goldman Sachs
New York
|
+$6.33M |
Top Sellers
| 1 | -$14.9M | |
| 2 | -$12.4M | |
| 3 | -$7.75M | |
| 4 |
VC
Vicus Capital
State College,
Pennsylvania
|
-$6.47M |
| 5 |
UCFA
United Capital Financial Advisors
Irving,
Texas
|
-$4.84M |